Join
Live feed
·
PRReleasevia Quantisnow
Jounce Therapeutics Inc. logo

Jounce Therapeutics Appoints Dmitri Wiederschain, Ph.D., as Chief Scientific Officer

ByQuantisnow·Wall Street's wire, on your screen.
JNCE· Jounce Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JNCE (Jounce Therapeutics Inc.) and more on Quantisnow.